Dallas Williams
- Surgery top 5%
- Oncology top 10%
- Urology top 2%
- Epidemiology
- Rheumatology top 5%
- Co-authors
- Randall E. MillikanColin P. DinneyLance C. PagliaroChristopher J. LogothetisPeter F. ThallSijin WenDanai DalianiH. Barton Grossman
- Topics
- Bladder and Urothelial Cancer Treatments (12 papers)Multiple and Secondary Primary Cancers (5 papers)Urinary and Genital Oncology Studies (5 papers)
- Cited by
- UrologySurgeryRheumatology
- Partner nations
- United StatesSpain
In The Last Decade
Dallas Williams
22 papers receiving 940 citations
Peers
Comparison fields: 5 of 62
- Surgery 700
- Oncology 252
- Urology 227
- Epidemiology 172
- Rheumatology 169
Countries citing papers authored by Dallas Williams
This map shows the geographic impact of Dallas Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dallas Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dallas Williams more than expected).
Fields of papers citing papers by Dallas Williams
This network shows the impact of papers produced by Dallas Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dallas Williams. The network helps show where Dallas Williams may publish in the future.
Co-authorship network of co-authors of Dallas Williams
This figure shows the co-authorship network connecting the top 25 collaborators of Dallas Williams. A scholar is included among the top collaborators of Dallas Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dallas Williams. Dallas Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Re: A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: Final results | 0 |
| 2 | 66 | |
| 3 | 116 | |
| 4 | 4 | |
| 5 | 30 | |
| 6 | 46 | |
| 7 | 6 | |
| 8 | 2 | |
| 9 | Phase I study of ispinesib (SB-715992) in combination with docetaxel in patients with advanced solid tumors. | 1 |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | Randomized clinical trial and economic analysis of four-layer compression bandaging for venous ulcers [Commentary] | 2 |
| 14 | 22 | |
| 15 | 1 | |
| 16 | 99 | |
| 17 | 28 | |
| 18 | 53 | |
| 19 | 13 | |
| 20 | 205 |
About Dallas Williams
Dallas Williams is a scholar working on Urology, Surgery and Internal Medicine, having authored 24 papers that have together received 966 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (12 papers), Multiple and Secondary Primary Cancers (5 papers) and Urinary and Genital Oncology Studies (5 papers). The work is most often cited by research in Urology (227 citations), Surgery (700 citations) and Rheumatology (169 citations). Dallas Williams has collaborated with scholars based in United States and Spain. Frequent co-authors include Randall E. Millikan, Colin P. Dinney, Lance C. Pagliaro, Christopher J. Logothetis, Peter F. Thall, Sijin Wen, Danai Daliani, H. Barton Grossman, Arlene O. Siefker‐Radtke and Curtis A. Pettaway. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.